Compare TGL & AEMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TGL | AEMD |
|---|---|---|
| Founded | 2020 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4M | 4.3M |
| IPO Year | 2022 | 2008 |
| Metric | TGL | AEMD |
|---|---|---|
| Price | $0.22 | $5.04 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $13.25 |
| AVG Volume (30 Days) | ★ 7.5M | 70.5K |
| Earning Date | 10-13-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 51.53 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,169,784.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 121.83 | N/A |
| 52 Week Low | $0.19 | $0.53 |
| 52 Week High | $587.80 | $29.45 |
| Indicator | TGL | AEMD |
|---|---|---|
| Relative Strength Index (RSI) | 24.14 | 48.40 |
| Support Level | $0.19 | $3.20 |
| Resistance Level | $3.30 | $6.69 |
| Average True Range (ATR) | 0.20 | 0.31 |
| MACD | -0.01 | -0.20 |
| Stochastic Oscillator | 2.29 | 15.76 |
Treasure Global Inc has created an online-to-offline e-commerce platform business model that offers consumers and merchants instant rebates and affiliate cashback programs, while providing a seamless e-payment solution with rebates in both e-commerce and physical retail or merchant settings. Its product is an internet application branded as the ZCITY app, which targets consumers by providing personalized deals based on their purchase history, location, and preferences. The Company has two reportable segments: payment processing and e-commerce operation in its ZCITY platform, and customized software development service, and the majority of revenue comes from payment processing and e-commerce operation in its ZCITY platform.
Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.